Thyroid cancer: towards a new standard treatment

In a low-risk thyroid cancer, four therapeutic strategies by iodine-131 after surgical resection of the gland are also effective, according to a study conducted by a team of the Institute Gustave Roussy. But one of these approaches is distinguished from others by a better tolerance and less irradiation of the body. It should therefore become the new standard for treatment as such.

A new standard treatment for thyroid cancer. To set the therapeutic strategy the most effective in the treatment of low thyroid cancer risk, after complete surgery of the thyroid, the Pr Martin Schlumberger (Chief of nuclear medicine at the Institute de cancerologie Gustave Roussy, Villejuif) and 24 French centers colleagues compared the 4 existing approaches 752 patients divided into four groups.

Thyroid cancer

The patients were treated by:

-withdrawal in thyroid hormone, and then 100 mill curies of iodine 131 (which corresponds to the standard treatment);

-thyroid hormone withdrawal, then 30 mill curies of iodine 131;

-thyroid hormone therapy, injections of human TSH recombinant then 100 mill curies of iodine 131; Continue reading “Thyroid cancer: towards a new standard treatment”

That we reserve the medicine of the future?

“The blind covered the view and the palsy walking.” What appeared to be a miracle or science fiction might well appear us in the near future terribly banal. Each week brings its share of new experiments by scientists seeking to push the boundaries of the restorative intervention of man on his body.

A chip with a kind of camera barely larger than the head of match which transmits information through electrodes implanted on the nerve cells of the retina helps a blind man to recover a partial vision. Electrodes judiciously placed in major muscles legs that allow moved to walk. An intervention in the gallbladder (read the interview of Professor Jacques Maraca) in 7 000 km from the operating room where the patient with a robot. It is not the top of the last competition Lupine but scientific experiments which have already given initial encouraging results.

Reserve Medical

New technologies for new century

On entering the new century two prestigious scientific journals, the British Medical Journal (BMJ) and the Journal of the American Medical Association (JAMA), asked experts to predict what would be the next advances in medicine. Continue reading “That we reserve the medicine of the future?”


Cancer of the thyroid gland is cancer that occurs most often in young people. What forms this cancer? What are the signs that can alert? Update on thyroid cancer.

-Thyroid: where is it placed? What is it?
-What are the signs that may indicate thyroid cancer?
-What are the risk factors of thyroid cancer?
-What is the treatment of thyroid cancer?


Thyroid: where is it placed? What is it?

The thyroid is a small gland at the base of the neck that secretes thyroid hormones rich in iodine, also known as T4 thyroxin and triiodothyronine (T3), which are involved in the functioning of most organs. Continue reading “WHAT ARE THE SIGNS OF A THYROID CANCER?”


Multiple myeloma or Kahler’s disease is a malignant bone tumor, bone cancer so … It originates from the bone marrow cells, which produce blood cells.

-Multiple myeloma, a bone cancer
-Multiple myeloma is a rare cancer
-How does one realize the diagnosis of multiple myeloma?
-The treatment of multiple myeloma


Multiple myeloma, a bone cancer

This disease is one of bone cancers. It is caused by a malignant proliferation of plasma cells (or plasma cells). Plasma cells are blood cells that specialize in the manufacture of antibodies. Produced in excess and abnormally shaped, they invade the bone marrow and tend to take the place of healthy blood cells. In parallel, plasma cells secrete substances that are gradually causing a destruction of bone tissue. For antibodies (proteins M), being produced by abnormal cells, they are ineffective, which increases the risk of infection. In addition, more difficult to remove, they tire more kidneys. Continue reading “MULTIPLE MYELOMA OR KAHLER’S DISEASE: BONE CANCER”


here are two types of bone cancer: primary cancer of the bone, rare, and secondary bone cancer or bone metastases, more frequent.

-Primary cancer of the bone
-Ewing’s sarcoma
-Multiple my Loma
-The role of surgery


Primary cancer of the bone

Primary cancers of the bones are localized cancers in the bone, or its immediate periphery, which develop from bone, cartilage or fibrous. They are quite rare. The main ones are osteosarcoma, chondrosarcoma, the Ewing’s sarcoma and multiple myeloma . The secondary bone cancer , or bone metastases, are remote locations, in bone cancer in another organ: prostate , kidney, breast, thyroid, … Continue reading “BONE CANCER: KNOW EVERYTHING”


Chondrosarcoma is part of bone cancer, bone tumor, but this is unusual to develop from cartilage cells. Unlike other bone cancer, chondrosarcoma does not respond to chemo or radiotherapy. Healing thus passes only through surgery.
-Bone cancer
-What are the symptoms of chondrosarcoma?
-Diagnosis and surgery of chondrosarcoma

Bone cancer

Primary cancers of the bones develop from bone tissue, fibrous or cartilaginous. Chondrosarcoma is a tumor that develops from cartilage cells. This is one of the two most common primary cancer of the bone with osteosarcoma. Chondrosarcoma primarily affects adults over the age of 30. The cartilages most often affected are the larger bones like the femur, tibia hummers, but the pelvis.

The areas most commonly affected are arms, legs and pelvis . However, any bone can be affected. Chondrosarcomas can develop either spontaneously or from a small pre-existing benign tumor which they will complicate the course. Moreover, there are two types of tumors: the most numerous are slow growing or low-grade malignancy, which means that the risk of metastases is low. The other type of tumor has a high degree of malignancy and tends to spread, to metastasize. Continue reading “CHONDROSARCOMA, BONE CANCER, CANCER OF THE CARTILAGE”


The osteosarcoma is the primary bone tumor most common. It usually affects young people and reached most often the knees, thighs and arms. Treatment of bone cancer that usually combines chemotherapy, radiotherapy and surgery.

-Osteosarcoma, a primary bone cancer
-The first signs of osteosarcoma
-Diagnosis and treatment of osteosarcoma


Osteosarcoma, a primary bone cancer

The osteosarcoma is one of the primary cancers of the bone, that is to say developed from bone cells, cartilage or fibrous tissue, as opposed to secondary cancers of the bone metastases that are of cancer in another organ. The osteosarcoma is primary bone cancer the most common, before the chondrosarcoma, Ewing’s sarcoma and multiple myeloma . Of unknown cause, osteosarcoma usually occurs in children and young adults, between 10 and 25 years. Continue reading “OSTEOSARCOMA: BONE CANCER”


We search, we check, we test, scientists continue to study possible health risks of mobile phones. Remember, he is regularly suspected of increasing the frequency of brain tumor.

-In search of a possible tumor
-Tumor rather on one side than the other?

In search of a possible tumor

Some think that we are relentlessly for several years to detect brain tumors related to the intensive use of mobile phones. Others believe that it applies to legitimately and conscientiously check their innocuite. Mais regardless of which side one takes, studies come since the 90s, when an increased incidence of lymphomas has been demonstrated in rats exposed to magnetic fields.


But so far, except a few trials discussed scientifically and methodologically, the results are consistent with a lack of increased risk of brain tumors in mobile. Portent enthusiasts, a new study led the research as far and sown doute. Etant given the rarity of brain tumors, or gliomas, this is what we call a case-control study, which compares the phone habits of a population of patients with glioma a control population free of tumor. The first group included nearly 1,000 subjects, in whom a brain tumor was diagnosed between late 2000 and early 2004. The control group consisted of about 1,700 people. Extensive data on their use of mobile phone were collected: date of commencement of use, frequency, aircraft type, analog or digital, etc.. Continue reading “BRAIN TUMORS AND MOBILE PHONE: THE DOUBT PERSISTS …”


Increasingly more precise surgery, chemotherapy, targeted therapy … If brain cancer remains disease with poor prognosis, the arsenal of therapeutic approaches to combat them is getting rich.

-Brain tumors: still dangerous
-Brain tumor: the revolution of surgery awake
-Brain tumor: towards targeted therapies

brain cancer

Brain tumors: still dangerous

Every year in France, more than 4,000 people learn they are carrying a tumor brain. According to the Institute of Health, the mortality rate associated with this type of injury would have begun a slight decline in recent years. However, brain tumors still result in the deaths of nearly 3,000 patients a year. Many current researches, however, give hope to see this number decrease. Continue reading “BRAIN TUMOR, BRAIN CANCER: NEW HOPE?”


Brain cancer has increased over the past twenty years, probably for environmental reasons. Exposure to certain carcinogens, including pesticides increases the risk of developing brain cancer. As for cell phones and antennas, they are strongly suspected …

-The different types of brain cancer
-What are the risk factors for brain cancer?
-Other risk factors for brain cancer:
-Can we prevent brain cancer?


The different types of brain cancer

In a majority of cases, cancer of the brain starts in another part of the body, before reaching the brain. The origin of a brain tumor may be another cancer that has metastasized (breast, lung, colon, melanoma, salivary gland ….). Continue reading “WHO IS AT RISK OF BRAIN CANCER?”